PROTAC: targeted drug strategy. Principles and limitations.
- DOI
- 10.1007/s11172-022-3659-z
- Published
- 2022
- Container
- Russian chemical bulletin = Izvestiia Akademii nauk. Seriia khimicheskaia
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s11172-022-3659-z,
title = {PROTAC: targeted drug strategy. Principles and limitations.},
author = {Koroleva OA and Dutikova YV and Trubnikov AV and Zenov FA and Manasova EV and Shtil AA and Kurkin AV},
year = {2022},
journal = {Russian chemical bulletin = Izvestiia Akademii nauk. Seriia khimicheskaia},
doi = {10.1007/s11172-022-3659-z},
url = {https://doi.org/10.1007/s11172-022-3659-z}
}RIS
TY - JOUR TI - PROTAC: targeted drug strategy. Principles and limitations. AU - Koroleva OA AU - Dutikova YV AU - Trubnikov AV AU - Zenov FA AU - Manasova EV AU - Shtil AA AU - Kurkin AV PY - 2022 JO - Russian chemical bulletin = Izvestiia Akademii nauk. Seriia khimicheskaia DO - 10.1007/s11172-022-3659-z UR - https://doi.org/10.1007/s11172-022-3659-z ER -
APA
OA, K., YV, D., AV, T., FA, Z., EV, M., AA, S., & AV, K. (2022). PROTAC: targeted drug strategy. Principles and limitations.. Russian chemical bulletin = Izvestiia Akademii nauk. Seriia khimicheskaia. https://doi.org/10.1007/s11172-022-3659-z
Source records
- pubmed · retrieved 2026-09-26T18:52:29.596Z